DK0680512T3 - Immunogent meningokok LPS og ydermembranvesikler og vaccine deraf - Google Patents
Immunogent meningokok LPS og ydermembranvesikler og vaccine derafInfo
- Publication number
- DK0680512T3 DK0680512T3 DK93921120T DK93921120T DK0680512T3 DK 0680512 T3 DK0680512 T3 DK 0680512T3 DK 93921120 T DK93921120 T DK 93921120T DK 93921120 T DK93921120 T DK 93921120T DK 0680512 T3 DK0680512 T3 DK 0680512T3
- Authority
- DK
- Denmark
- Prior art keywords
- outer membrane
- omp
- pct
- lipopolysaccharide
- directed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL9201716A NL9201716A (nl) | 1992-10-02 | 1992-10-02 | Buitenmembraanvesikel dat voorzien is van een groep polypeptiden welke ten minste de immuunwerking van aan membraan gebonden buitenmembraaneiwitten (OMP's) hebben, werkwijze ter bereiding ervan alsmede een vaccin dat een dergelijk buitenmembraanvesikel omvat. |
| PCT/NL1993/000163 WO1994008021A1 (en) | 1992-10-02 | 1993-07-30 | Immunogenic meningococcal lps and outer membrane vesicles and vaccine therefrom |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0680512T3 true DK0680512T3 (da) | 2007-10-01 |
Family
ID=19861338
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK93921120T DK0680512T3 (da) | 1992-10-02 | 1993-07-30 | Immunogent meningokok LPS og ydermembranvesikler og vaccine deraf |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5705161A (da) |
| EP (1) | EP0680512B1 (da) |
| JP (1) | JPH08501940A (da) |
| AT (1) | ATE364702T1 (da) |
| AU (1) | AU684720B2 (da) |
| CA (1) | CA2146145C (da) |
| DE (1) | DE69334147T2 (da) |
| DK (1) | DK0680512T3 (da) |
| ES (1) | ES2289739T3 (da) |
| FI (1) | FI951535L (da) |
| NL (1) | NL9201716A (da) |
| NO (1) | NO321651B1 (da) |
| PT (1) | PT680512E (da) |
| WO (1) | WO1994008021A1 (da) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7118757B1 (en) * | 1988-12-19 | 2006-10-10 | Wyeth Holdings Corporation | Meningococcal class 1 outer-membrane protein vaccine |
| US20020028215A1 (en) | 1999-08-09 | 2002-03-07 | Jagath L. Kadurugamuwa | Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same |
| BR9609882A (pt) * | 1995-08-04 | 1999-07-27 | Univ Guelph | Vacina processos para preparar a mesma para tratar uma doença infecciosa para inserir uma molécula de ácido nucleico em uma célula de marcaç o para administrar um agente terapêutico a um hospedeiro e para triar um antígeno imunogênico de um patógeno uso de uma vesícula de membrana composição farmacêutica sistema de liberação de drogas e vesícula de membrana |
| US6872398B2 (en) * | 1995-12-22 | 2005-03-29 | The United States Of America As Represented By The Secretary Of The Army | Conjugate vaccine against gram-negative bacterial infections |
| US6645503B1 (en) * | 1998-03-10 | 2003-11-11 | Wyeth Holdings Corporation | Antigenic conjugates of conserved lipopolysaccharides of gram negative bacteria |
| GB9823978D0 (en) | 1998-11-02 | 1998-12-30 | Microbiological Res Authority | Multicomponent meningococcal vaccine |
| US10967045B2 (en) | 1998-11-02 | 2021-04-06 | Secretary of State for Health and Social Care | Multicomponent meningococcal vaccine |
| US6514948B1 (en) * | 1999-07-02 | 2003-02-04 | The Regents Of The University Of California | Method for enhancing an immune response |
| US6531131B1 (en) | 1999-08-10 | 2003-03-11 | The United States Of America As Represented By The Department Of Health And Human Services | Conjugate vaccine for Neisseria meningitidis |
| EP2364726A3 (en) * | 1999-09-30 | 2011-11-09 | Isis Innovation Limited | Vaccine against neisseria infection |
| MXPA03000822A (es) * | 2000-07-27 | 2004-11-01 | Childrens Hosp & Res Ct Oak | Vacunas para proteccion de espectro amplio contra enfermedades causadas por neisseria meningitidis. |
| AU2003239125A1 (en) * | 2002-03-20 | 2003-10-08 | Emory University | Neisseria mutants, lipooligosaccharides and immunogenic compositions |
| CN1674933B (zh) * | 2002-08-02 | 2012-09-26 | 葛兰素史密丝克莱恩生物有限公司 | 疫苗组合物 |
| RU2364418C2 (ru) * | 2002-08-02 | 2009-08-20 | ГлаксоСмитКлайн Байолоджикалз с.а. | ВАКЦИННЫЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ЛИПОПОЛИСАХАРИДЫ ИММУНОТИПА L2 И/ИЛИ L3, ПРОИСХОДЯЩИЕ ИЗ ШТАММА NEISSERIA MENINGITIDIS IgtB- |
| GB0220194D0 (en) | 2002-08-30 | 2002-10-09 | Chiron Spa | Improved vesicles |
| EP2351579B1 (en) | 2002-10-11 | 2016-09-21 | Novartis Vaccines and Diagnostics S.r.l. | Polypeptide vaccines for broad protection against hypervirulent meningococcal lineages |
| CA2506318C (en) | 2002-11-15 | 2011-07-12 | Chiron Srl | Unexpected surface proteins in neisseria meningitidis |
| GB0227346D0 (en) | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
| DK1587537T3 (da) | 2003-01-30 | 2012-07-16 | Novartis Ag | Injicerbare vacciner mod multiple meningococ-serogrupper |
| GB0323103D0 (en) | 2003-10-02 | 2003-11-05 | Chiron Srl | De-acetylated saccharides |
| GB0408977D0 (en) | 2004-04-22 | 2004-05-26 | Chiron Srl | Immunising against meningococcal serogroup Y using proteins |
| US7537766B2 (en) * | 2004-08-30 | 2009-05-26 | Wyeth | Neisseria meningitidis inner core lipo-oligosaccharide epitopes, multivalent conjugates thereof and immunogenic compositions thereof |
| GB0424092D0 (en) | 2004-10-29 | 2004-12-01 | Chiron Srl | Immunogenic bacterial vesicles with outer membrane proteins |
| CN101107007B (zh) | 2005-01-27 | 2011-08-17 | 奥克兰儿童医院及研究中心 | 对脑膜炎奈瑟球菌所致疾病具有广谱保护作用的gna1870囊泡疫苗 |
| GB0524066D0 (en) | 2005-11-25 | 2006-01-04 | Chiron Srl | 741 ii |
| ES2337309T5 (es) | 2006-06-12 | 2013-07-30 | Glaxosmithkline Biologicals S.A. | Vacuna |
| AU2009215364B2 (en) | 2008-02-21 | 2014-09-18 | Glaxosmithkline Biologicals S.A. | Meningococcal fHBP polypeptides |
| MX2010012999A (es) * | 2008-05-30 | 2012-03-07 | U S A As Represented By The Secretary Of The Army On Behalf Of Walter Reed Army | Vacuna de vesícula de membrana externa nativa multivalente del meningococo, método para su fabricación y uso. |
| CN104548082A (zh) | 2009-03-24 | 2015-04-29 | 诺华股份有限公司 | 为脑膜炎球菌因子h结合蛋白添加佐剂 |
| EP3017826A1 (en) | 2009-03-24 | 2016-05-11 | Novartis AG | Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates |
| WO2010130898A2 (fr) * | 2009-05-14 | 2010-11-18 | Sanofi Pasteur | Vaccin meningocoque a base de lipooligosaccharide (los) provenant de souches modifiees de neisseria meningitidis d'immunotype l6 |
| WO2010134225A1 (ja) * | 2009-05-20 | 2010-11-25 | 国立大学法人鳥取大学 | 部分糖鎖エピトープを用いた、病原性ナイセリア属細菌感染の検出方法およびそれら細菌に対するワクチン |
| AU2010288239B2 (en) | 2009-08-27 | 2014-01-16 | Novartis Ag | Adjuvant comprising aluminium, oligonucleotide and polycation |
| WO2011024072A2 (en) | 2009-08-27 | 2011-03-03 | Novartis Ag | Hybrid polypeptides including meningococcal fhbp sequences |
| CN102724988B (zh) | 2009-09-30 | 2014-09-10 | 诺华股份有限公司 | 脑膜炎球菌fHBP多肽的表达 |
| CA2779816A1 (en) | 2009-10-27 | 2011-05-05 | Novartis Ag | Modified meningococcal fhbp polypeptides |
| WO2012020326A1 (en) | 2010-03-18 | 2012-02-16 | Novartis Ag | Adjuvanted vaccines for serogroup b meningococcus |
| WO2011161653A1 (en) | 2010-06-25 | 2011-12-29 | Novartis Ag | Combinations of meningococcal factor h binding proteins |
| EP2797624A1 (en) | 2011-12-29 | 2014-11-05 | Novartis AG | Adjuvanted combinations of meningococcal factor h binding proteins |
| CN106661092B (zh) | 2014-02-28 | 2021-07-06 | 葛兰素史密丝克莱恩生物有限公司 | 修饰的脑膜炎球菌fHbp多肽 |
| GB201712824D0 (en) | 2017-08-10 | 2017-09-27 | Glaxosmithkline Biologicals Sa | Multi-functionalized nOMV Conjugates |
| BR112021002710A2 (pt) | 2018-08-14 | 2021-11-16 | Evercyte Gmbh | Vesículas extracelulares específicas alvo (tev), uma preparação, uma proteína de superfície da vesícula extracelular específica alvo, um domínio extravesicular específico alvo da mesma. codificação de ácido nucleico, biblioteca de tev, preparação farmacêutica e sua utilização; métodos de produção |
| AU2022208435A1 (en) | 2021-01-18 | 2023-08-10 | Conserv Bioscience Limited | Coronavirus immunogenic compositions, methods and uses thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU640118B2 (en) * | 1988-12-19 | 1993-08-19 | De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezonheid En Cultuur | Meningococcal class 1 outer-membrane protein vaccine |
| NL9101359A (nl) * | 1991-08-07 | 1993-03-01 | Nederlanden Staat | Nieuw saccharide-peptide-conjugaat, werkwijze ter bereiding ervan alsmede een vaccin dat een dergelijk saccharide-peptide-conjugaat omvat. |
-
1992
- 1992-10-02 NL NL9201716A patent/NL9201716A/nl not_active Application Discontinuation
-
1993
- 1993-07-30 WO PCT/NL1993/000163 patent/WO1994008021A1/en not_active Ceased
- 1993-07-30 ES ES93921120T patent/ES2289739T3/es not_active Expired - Lifetime
- 1993-07-30 US US08/411,727 patent/US5705161A/en not_active Expired - Lifetime
- 1993-07-30 JP JP6508917A patent/JPH08501940A/ja active Pending
- 1993-07-30 AT AT93921120T patent/ATE364702T1/de active
- 1993-07-30 CA CA002146145A patent/CA2146145C/en not_active Expired - Lifetime
- 1993-07-30 AU AU48351/93A patent/AU684720B2/en not_active Ceased
- 1993-07-30 FI FI951535A patent/FI951535L/fi unknown
- 1993-07-30 EP EP93921120A patent/EP0680512B1/en not_active Expired - Lifetime
- 1993-07-30 DE DE69334147T patent/DE69334147T2/de not_active Expired - Lifetime
- 1993-07-30 PT PT93921120T patent/PT680512E/pt unknown
- 1993-07-30 DK DK93921120T patent/DK0680512T3/da active
-
1995
- 1995-03-28 NO NO19951181A patent/NO321651B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PT680512E (pt) | 2007-09-25 |
| NO321651B1 (no) | 2006-06-19 |
| DE69334147T2 (de) | 2008-02-14 |
| AU684720B2 (en) | 1998-01-08 |
| AU4835193A (en) | 1994-04-26 |
| JPH08501940A (ja) | 1996-03-05 |
| NO951181D0 (no) | 1995-03-28 |
| US5705161A (en) | 1998-01-06 |
| CA2146145C (en) | 2009-10-27 |
| EP0680512A1 (en) | 1995-11-08 |
| ATE364702T1 (de) | 2007-07-15 |
| ES2289739T3 (es) | 2008-02-01 |
| FI951535A7 (fi) | 1995-06-01 |
| EP0680512B1 (en) | 2007-06-13 |
| WO1994008021A1 (en) | 1994-04-14 |
| NO951181L (no) | 1995-06-01 |
| FI951535L (fi) | 1995-06-01 |
| NL9201716A (nl) | 1994-05-02 |
| CA2146145A1 (en) | 1994-04-14 |
| DE69334147D1 (de) | 2007-07-26 |
| FI951535A0 (fi) | 1995-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE364702T1 (de) | Immunogene meningococcale lps und aussenmembranvesikel und impstoff daraus | |
| WO1990006696A3 (en) | Meningococcal class 1 outer-membrane protein vaccine | |
| AU657487B2 (en) | Nucleotide sequence coding for an outer membrane protein from neisseria meningitidis and use of said protein in vaccine preparations | |
| NO943739L (no) | Vaksiner inneholdende vesikler basert på ikke-ioniske overflate-aktive midler | |
| ES2063965T3 (es) | Vacunas para haemophilus influenzae no tipificable. | |
| ATE252602T1 (de) | Meningokokkus b-epitop ausbildende monoklonale antikoerper und deren verwendung zur herstellung von impfstoffzusammenstellungen | |
| KR900009095A (ko) | 합성 항원, 이의 제조방법 및 용도 | |
| DK55891A (da) | Matrix med immunomodulerende virkning | |
| Muttilainen et al. | TheNeisseria meningitidisouter membrane protein P1 produced inBacillus subtilisand reconstituted into phospholipid vesicles elicits antibodies to native P1 epitopes | |
| DE68915046D1 (de) | Haemophilus influenzae Typ B Polysaccharid-Aussermembranprotein-Konjugat als Impfstoff. | |
| FI924457A0 (fi) | Kompositioner och behandlingsfoerfarande foer lunginflammation i djur | |
| SE9402880D0 (sv) | New peptide derivatives | |
| CA2007248A1 (en) | Meningococcal class 1 outer-membrane protein vaccine | |
| BR9905780A (pt) | Antìgenos vacinais de leptospira para prevenção da laptospirose | |
| Van Welzijn | Jay R. Luly; Megumi Kawai; Or Yat Sun; Paul Wiedeman; Rolf Wagner Abbott Laboratories, Libertyville, IL, United States | |
| IL98839A0 (en) | Vaccines comprising protein of the outer membrane of neisseria meningitidis | |
| DK0873136T3 (da) | Specifik immunforögende faktor med höj fluorescens og fremgangsmåder til anvendelse af samme | |
| ZA915627B (en) | The class ii protein of the outer membrane of neisseria meningitidis having immunologic carrier and enhancement properties,and vaccines containing same |